Nuvalent

Nuvalent reports positive data from Phase I/II NSCLC therapy trial
Clinical Trials Arena
Mon, 10/31/22 - 10:22 am
Nuvalent
non-small cell lung cancer
NVL-520
clinical trials
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
BioSpace
Thu, 07/29/21 - 10:59 pm
IPOs
Nuvalent
Rallybio
Icosavax
NASDAQ
Nuvalent joins the IPO party less than 6 months after launch, while Icosavax kicks its 'soccer ball' VLPs to Nasdaq
Endpoints
Wed, 07/7/21 - 11:07 am
Nuvalent
IPOs
Icosavax
VLP platform
Three Companies Land Fresh Funds to Advance Pipelines
BioSpace
Tue, 05/11/21 - 10:04 pm
funding
Nuvalent
Aetion
real world evidence
RWE
Adaptive Phage Therapeutics
Nuvalent bags $135M to trial resistance-beating kinase inhibitors in lung cancer
Fierce Biotech
Tue, 05/11/21 - 11:05 am
Nuvalent
funding
lung cancer